首页> 外文期刊>Clinical nuclear medicine >Conjunctival MALT Lymphoma Utility of FDG PET/CT for Diagnosis, Staging, and Evaluation of Treatment Response
【24h】

Conjunctival MALT Lymphoma Utility of FDG PET/CT for Diagnosis, Staging, and Evaluation of Treatment Response

机译:FDG PET / CT的结膜MALT淋巴瘤用于诊断,分期和评估治疗反应的效用

获取原文
获取原文并翻译 | 示例
           

摘要

A 67-year-old woman was referred for staging of a mucosa-associated lymphoid tumor lymphoma involving the left conjunctiva. CT scan had shown paravertebral and pelvic masses, and a breast nodule. FDG PET/CT demonstrated moderately increased uptake in the left ocular conjunctiva and confirmed the paravertebral and pelvic masses and the breast nodule. Moreover, abnormal FDG uptake was shown in 2 breast nodules, the flank, the gluteus maximus, and the gastric cardia. The patient received 6 cycles of rituximab-bendamustine chemotherapy with a complete clinical and metabolic response at the 6-month follow-up PET/CT and remained relapse-free without visual acuity problem after a 36-month follow-up.
机译:一名67岁妇女因涉及左结膜的粘膜相关淋巴样肿瘤淋巴瘤的分期而被转诊。 CT扫描显示椎旁和骨盆肿块,以及乳腺结节。 FDG PET / CT证实左眼结膜摄取适度增加,并确认椎旁和骨盆肿块以及乳腺结节。此外,在2个乳腺结节,腹侧,臀大肌和胃card门中显示出异常的FDG摄取。该患者在6个月的随访PET / CT中接受了6个周期的利妥昔单抗-苯达莫司汀化疗,具有完全的临床和代谢反应,并且在36个月的随访后仍保持无复发,无视力问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号